Readthrough of premature termination codons in the adenomatous polyposis coli gene restores its biological activity in human cancer cells.

Abstract

The APC tumor suppressor gene is frequently mutated in human colorectal cancer, with nonsense mutations accounting for 30% of all mutations in this gene. Reintroduction of the WT APC gene into cancer cells generally reduces tumorigenicity or induces apoptosis. In this study, we explored the possibility of using drugs to induce premature termination codon (PTC) readthrough (aminoglycosides, negamycin), as a means of reactivating endogenous APC. By quantifying the readthrough of 11 nonsense mutations in APC, we were able to identify those giving the highest levels of readthrough after treatment. For these mutations, we demonstrated that aminoglycoside or negamycin treatment led to a recovery of the biological activity of APC in cancer cell lines, and showed that the level of APC activity was proportional to the level of induced readthrough. These findings show that treatment with readthrough inducers should be considered as a potential strategy for treating cancers caused by nonsense mutations APC gene. They also provide a rational basis for identifying mutations responsive to readthrough inducers.

• Authors: Célia Floquet, Jean-Pierre Rousset, Laure Bidou
• Journal: PloS one (PLoS One) Vol. 6 Issue 8 Pg. e24125 ( 2011) ISSN: 1932-6203 [Electronic] United States
• PMID: 21909382 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Adenomatous Polyposis Coli Protein
• Aminoglycosides
• Anti-Bacterial Agents
• Codon, Nonsense
• DNA, Complementary

Topics

• Adenomatous Polyposis Coli Protein (genetics, metabolism)
• Aminoglycosides (pharmacology)
• Anti-Bacterial Agents (pharmacology)
• Base Sequence
• Blotting, Western
• Cell Line, Tumor
• Codon, Nonsense (genetics)
• Colorectal Neoplasms (genetics)
• DNA, Complementary (genetics)
• Genes, APC
• Humans
• Molecular Sequence Data